Stoke Therapeutics, Inc. STOK Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s operating lease liabilities (current)?
- Stoke Therapeutics, Inc. (STOK) reported operating lease liabilities (current) of $2.43M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Stoke Therapeutics, Inc.'s operating lease liabilities (current) increased by 3.5% year-over-year, from $2.35M to $2.43M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s operating lease liabilities (current) has grown at a 23.0% compound annual growth rate (CAGR), from $1.07M to $3.01M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.